sterling logo reverse

Extended Bench™ in action


CONTRIBUTOR:

alex bissegger

extended bench in action

Today, pharmaceutical development and manufacturing demands greater agility than ever—as therapeutic innovation expands, technological advancements enable new possibilities, and competition continues to grow. This level of agility inherently necessitates a high level of collaboration, allowing teams to rapidly overcome challenges and run processes in parallel while avoiding duplicative or siloed work.

In one project at Sterling, a customer required regulatory starting material (RSM) development and GMP process validation for a late phase molecule, as well as a second-generation asset to be developed in tandem for upcoming toxicology studies. With medicinal chemistry procedures provided by the customer as a starting point, the Sterling team was tasked with developing reproducible processes and quality materials within the customer’s desired timeframe and budget.

This project highlights the effectiveness of Sterling’s Extended Bench™ model, which enables our cross-site teams to work on diverse project components best aligned with their infrastructure and areas of expertise, while maintaining a primary point of contact for continued alignment with the customer. Read on to discover how four of Sterling’s global sites worked together to deliver the customer high-quality, right-first-time results.

sterling locations map

Wisconsin, US

Specialty spotlight

Chemistry and analytical development, GLP and GMP manufacturing, stability and dFMEA studies

More

North Carolina, US

Specialty spotlight

Early phase chemistry and analytical development, process optimisation

More

Cramlington, UK

Specialty spotlight

Solid state characterisation and crystallisation development, late phase chemistry, analytical development, and manufacturing

More

Newcastle Biosphere, UK

Specialty Spotlight

Route scouting, proof of concept, and reference standard synthesis

More

wisconsin spotlight

Chemistry and analytical development, GLP and GMP manufacturing, stability and dFMEA studies

Sterling’s Wisconsin site, which specialises in full API development through to commercial manufacturing, served as the home base for this project, with a dedicated project manager to serve as the customer’s main point of contact and coordinate responsibilities across all Sterling facilities involved.


Key responsibilities for the Wisconsin site included:

icon target

Process and analytical development for the second-generation asset, ensuring robust, scalable, and reproducible routes in preparation for late phase manufacturing

icon deprotection

Analytical method development and validation for both customer assets, ensuring alignment with regulatory standards and readiness for GLP and GMP manufacturing

solid state

Process development for the late phase material, and validation for registered GMP steps

icon synthesis

Risk and control strategies, including nitrosamine impurity synthesis to establish sensitive detection limits, as well as Design Failure Mode and Effects Analysis (dFMEA) to identify and mitigate potential points of failure through development and manufacturing

Why it matters:

By centralising process governance and project management at the Wisconsin site, Sterling ensured that complex workstreams across multiple facilities advanced seamlessly. The Wisconsin site played a crucial role not only through supporting development and manufacturing requirements, but also by minimising communication gaps and streamlining decision-making for the customer.

sterling north carolina

Early phase chemistry and analytical development, process optimisation

The North Carolina site is well-known for its extensive early phase development expertise. Working in parallel with the other sites, the North Carolina team played an integral role in developing and optimising a scalable process for the second-generation material to carry through to larger scale manufacturing.


Key responsibilities for the North Carolina site included:

icon target

Process development and optimisation for the second-generation asset to ensure scalability and reproducibility

icon catalyst

Isotope-labeled material synthesis to support pharmacokinetic assays and evaluate bioavailability of the second-generation asset

data generation

Robust early phase data generation to enable a smooth transition to Wisconsin for eventual clinical and commercial manufacturing

Why it matters:

By establishing a well-optimised and reproducible process early on, the North Carolina team helped de-risk downstream scale-up and manufacturing. Their early phase expertise and ability to generate robust data helped to accelerate the overall project timeline.

newcastle office

Route scouting, proof of concept, and reference standard synthesis

Sterling’s Newcastle Biosphere site provides additional early phase expertise across discovery and development, allowing them to flexibly support route scouting and proof of concept in tandem with the North Carolina site’s early phase work.


Key responsibilities for the Newcastle Biosphere site included:

icon scale

Exploration and testing of alternative pathways for the second-generation asset to identify opportunities for greater efficiency and scalability

icon target

Proof-of-concept process improvements to enhance efficiency as GLP manufacturing occurred at the Wisconsin site

icon qualification

Synthesis and qualification of reference standards for regulatory starting material (RSM) and downstream GMP steps, enabling accurate impurity profiling and method validation

Why it matters:

The Newcastle Biosphere team’s agile feasibility work helped to de-risk the process early on, while enabling faster and more accurate decision-making for the Cramlington and Wisconsin sites down the line.

cramlington office

Solid state characterisation and crystallisation development, late phase chemistry, analytical development, and manufacturing

With expertise in full-lifecycle development and manufacturing along with solid state chemistry, the Cramlington team played an integral role in RSM development and solid state characterisation.


Key responsibilities for the Cramlington site included:

solid state

Advanced solid state studies to define physical properties for the second-generation asset, plus crystallisation development to support consistent particle size and downstream processing

icon target

RSM method development and validation for the late phase asset to support upcoming regulatory filings

rsm manufacturing

Late phase RSM manufacturing under controlled conditions to provide qualified material for GMP synthesis while ensuring process scalability

Why it matters:

The Cramlington team ensured that the programme was supported by robust controls and reliable RSM supply as activities at other sites progressed, enabling scalability and regulatory success.


extension of your team

Working together to maximise success

Sterling’s Extended Bench™ model made it possible to carry out distinct yet equally important project components in parallel, while capitalising on each site’s areas of expertise and allowing the customer to achieve their project objectives on time and within budget. At every step of the way, the customer worked collaboratively with the Sterling team through a dedicated project manager, who served as the customer’s point of contact and a coordinator across Sterling’s internal teams to ensure consistency, alignment, and rapid problem-solving.

Some key advantages of our Extended Bench™ model include:

icon flexibility

Flexibility to allocate time and resources across Sterling’s global network of facilities and numerous areas of technical expertise

icon agility

Agile responsiveness and the ability to adapt rapidly as project requirements shift

icon acceleration

Accelerated time to market, with distinct processes run in parallel

icon transparency

Full transparency in resource allocation and costs

icon experts

Access to multiple experts and teams across the business, while retaining one, dedicated point of contact for continued alignment without added complexity